Eli Lilly Dramatically Escalates Efforts to Restrict Access to 340B Pricing


Note from the Publisher and CEO Ted Slafsky:  Bronwyn Mixter is filling in for Tom Mirga this week.  If you have story ideas or tips, feel free to reach her at bronwyn.mixter@340breport.com or 703-403-5926. We’re pleased to include

Read More »

Drug Store Chains Want HHS to Block Pharma’s Moves Against 340B Contract Pharmacy

Note from the Publisher and CEO:  Happy Wednesday.  Bronwyn Mixter is filling in for Tom Mirga this week and next week.  If you have story ideas or tips, feel free to reach her at bronwyn.mixter@340breport.com or 703-403-5926.

Read More »

Breaking News

BREAKING: Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts

Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts

Prescription drug information technology company Kalderos announced today it is launching a platform called 340B Pay on Sept. 8 “to facilitate 340B discounts

Read More »

340B Supply Chain Partners Push Back Against Manufacturer Contract Pharmacy Requests

Note from Publisher and CEO Ted Slafsky: We are pleased that Bronwyn Mixter is filling in for Tom Mirga for the next two weeks while Tom takes a late summer break. Bronwyn is a veteran health care reporter who covered

Read More »

Breaking News

BREAKING: Novartis the Latest to Seek 340B Contract Pharmacy Claims Data

A Message from Publisher and CEO Ted Slafsky: I hope all is well. For now, we have more requests for 340B Report sponsorships than space available. Fortunately, we are creating a new website and newsletter platform that will accommodate our growing

Read More »

Breaking News

BREAKING: AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

Drug manufacturer AstraZeneca today sent letters to 340B covered entities and its wholesale pharmacy contacts telling them that, effective Oct. 1, it

Read More »

Health Centers Seek Meeting With Merck About its 340B Contract Pharmacy Data Request

A Message from Publisher and CEO Ted Slafsky: I encourage you all to read today’s sponsored content article from SPARx, a division of Comprehensive Pharmacy Services, about the importance of relationships with key stakeholders in hospital-based specialty pharmacy. The ability

Read More »

Sanofi Joins Growing List of Drug Companies Challenging 340B Contract Pharmacy

Note from Publisher and CEO Ted Slafsky: We are pleased to welcome health care technology company 340Basics as our latest sponsor. We look forward to working with them and encourage you to check them out. Please also be sure to read

Read More »

Breaking News

BREAKING: Hospitals and Other Providers Ask HHS to Halt Lilly and Merck’s Clampdowns on 340B; Companies Defend Their Positions

Hospitals and Other Providers Ask HHS to Halt Lilly and Merck’s Clampdowns on 340B; Companies Defend Their Positions

The U.S. Health and Human Services Department (HHS) should halt drug manufacturers Eli Lilly and Merck’s recent separate actions to curtail or

Read More »

340B ESP Wants to Be Pharma’s Go-to on 340B Duplicate Discounts. Kalderos Says Not So Fast.

A Message from Publisher and CEO Ted Slafsky: We recently welcomed FQHC 340B Compliances Services to our growing list of sponsors. In today’s sponsored content article, FQHC 340B Lead Consultant Michael Gonzalez offers five great tips on how covered entities can

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live